Skip to main content
. 2022 May 19;29(5):3698–3707. doi: 10.3390/curroncol29050296

Table 1.

CPQR’s endorsed PRO measures.

Disease Site PRO Measure
All cancer (general) Edmonton Symptom Assessment Screening (ESAS)
Bone metastasis Brief Pain Inventory (BPI)
Prostate cancer Expanded Prostate
Cancer Index Composite (EPIC)
Head and neck cancer MD Anderson Symptom Inventory for Head and Neck (MDASI-HN)
Gynecological cancer Cervical cancer-specific quality of life module of the European Organization for Research and Treatment of Cancer (EORTC QLQ-CX24)